• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493919912300
Device Problem Occlusion Within Device (1423)
Patient Problems Myocardial Infarction (1969); Reocclusion (1985)
Event Date 03/07/2018
Event Type  Injury  
Manufacturer Narrative
Device is combination product.Device evaluated by mfr: the complaint device was not received for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The investigation conclusion is anticipated procedural complication as the event is due to a known physiological effect of the procedure noted within the directions for use, and/or device labeling.(b)(4).
 
Event Description
(b)(6) study.It was reported that myocardial infarction and restenosis occurred.In (b)(6) 2013, the subject presented with stable angina (ccs classification: 2) and was referred for cardiac catheterization.Target lesion #1 was located in the proximal right coronary artery (rca) with 75% stenosis and was 10 mm long with a reference vessel diameter of 3.0 mm.Target lesion #1 was treated with pre-dilatation and placement of a 3.00 x 12 mm study stent.Residual stenosis was 0%.The subject was discharged on dual antiplatelet therapy.In (b)(6) 2018, the subject presented with complaints of chest pain.Cardiac enzymes were elevated consistent with spontaneous myocardial infarction.The subject was placed on medicated, hospitalized, and referred for cardiac catheterization.The subject was evaluated found to be a poor candidate for surgery so it was decided to perform staged percutaneous coronary intervention to the stenosis in rca and left main.The 80% stenosis in the distal portion of the previously placed study stent in the proximal rca was treated with pre dilatation and placement of a 2.25x15mm non-bsc drug eluting stent.Post procedure, the residual stenosis was 0% with timi 3 flow.The 90% stenosed left main coronary artery was treated with pre dilatation and placement of a 4.00x16mm synergy stent in the proximal left anterior descending artery extending back into the mid left main.Post dilatation, the residual stenosis was 0% with timi 3 flow.The subject was discharged in stable condition.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that in (b)(6) 2018, the subject presented with chest tightness associated with shortness of breath and was given nitroglycerin and aspirin for the chest pain.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7396931
MDR Text Key104362351
Report Number2134265-2018-02761
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/16/2013
Device Model NumberH7493919912300
Device Lot Number15626574
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/13/2018
Initial Date FDA Received04/04/2018
Supplement Dates Manufacturer Received04/05/2018
Supplement Dates FDA Received04/19/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/08/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age83 YR
-
-